These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3575560)
1. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560 [TBL] [Abstract][Full Text] [Related]
2. Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures. Rothschild AJ; Schatzberg AF; Langlais PJ; Lerbinger JE; Miller MM; Cole JO Psychiatry Res; 1987 Feb; 20(2):143-53. PubMed ID: 2883694 [TBL] [Abstract][Full Text] [Related]
3. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study. Maj M; Ariano MG; Arena F; Kemali D Neuropsychobiology; 1984; 11(3):168-73. PubMed ID: 6089030 [TBL] [Abstract][Full Text] [Related]
4. Platelet MAO activity and the dexamethasone suppression test in depressed patients. Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239 [TBL] [Abstract][Full Text] [Related]
5. Platelet MAO activity and the cortisol response to dexamethasone in major depression. Meltzer HY; Lowy MT; Locascio JJ Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495 [TBL] [Abstract][Full Text] [Related]
6. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477 [TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression. Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113 [No Abstract] [Full Text] [Related]
8. Effects of glucocorticoids on plasma catecholamines in depression. Rupprecht R; Rupprecht M; Rupprecht C; Sofic E; Barocka A; Beck G; Noder M; Riederer P Psychiatry Res; 1989 Aug; 29(2):187-98. PubMed ID: 2798597 [TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase and cortisol response in depression and schizophrenia. Pandey GN; Sharma RP; Janicak PG; Davis JM Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943 [TBL] [Abstract][Full Text] [Related]
10. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol. Wahlund B; Sääf J; Wetterberg L Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087 [TBL] [Abstract][Full Text] [Related]
11. [Effects of sodium oxybutyrate on the level of catecholamines and serotonin and monoamine oxidase activity in patients with alcoholism]. Treskov VG; Krashkina II; Tsirenina ML; Koltovaia NA; Nikol'skaia GV; Baturin AK; Gapparov MM; Mel'nik EI; Maĭskiĭ AI Biull Eksp Biol Med; 1989 Jul; 108(7):62-4. PubMed ID: 2804304 [TBL] [Abstract][Full Text] [Related]
12. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients. Loosen PT; Marciniak R Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464 [TBL] [Abstract][Full Text] [Related]
14. Platelet MAO activity and the dexamethasone suppression test in bipolar depression. Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065 [TBL] [Abstract][Full Text] [Related]
15. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients. Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851 [TBL] [Abstract][Full Text] [Related]
16. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test. Ravindran AV; Bialik RJ; Lapierre YD J Affect Disord; 1994 Jun; 31(2):111-7. PubMed ID: 8071473 [TBL] [Abstract][Full Text] [Related]
17. Relationship of platelet MAO activity to characteristics of major depressive illness. Georgotas A; McCue RE; Friedman E; Hapworth WE; Kim OM; Cooper TB; Chang I; Stokes PE Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323 [TBL] [Abstract][Full Text] [Related]
18. High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Barnes RF; Veith RC; Borson S; Verhey J; Raskind MA; Halter JB Am J Psychiatry; 1983 Dec; 140(12):1623-5. PubMed ID: 6650697 [TBL] [Abstract][Full Text] [Related]
19. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases. Goldstein DS; Castillo G; Sullivan P; Sharabi Y J Pharmacol Exp Ther; 2021 Nov; 379(3):253-259. PubMed ID: 34503991 [TBL] [Abstract][Full Text] [Related]
20. Platelet monoamine oxidase activity in patients with panic disorder. Gorman J; Liebowitz MR; Fyer AJ; Levitt M; Baron M; Davies S; Klein DF Biol Psychiatry; 1985 Aug; 20(8):852-7. PubMed ID: 4027301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]